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Abstract
Epidemiological studies of those exposed occupationally to ionising radiation
offer an important opportunity to directly check the assumptions underlying
the international system of radiological protection against low-level radiation
exposures. Recent nuclear worker studies, notably the International Nuclear
Workers Study (INWORKS) and studies of the Mayak workforce in Russia,
provide powerful investigations of a wide range of cumulative photon doses
received at a low dose-rate over protracted periods, and broadly confirm
radiation-related excess risks of leukaemia and solid cancers at around the
levels predicted by standard risk models derived mainly from the experience
of the Japanese atomic-bomb survivors acutely exposed principally to gamma
radiation. However, the slope of the dose-response for solid cancers expressed
in terms of the excess relative risk per unit dose, ERR/Gy, differs between
INWORKS and Mayak, such that when compared with the slope derived from
the atomic-bomb survivors, INWORKS does not provide obvious support for
the use in radiological protection of a dose and dose-rate effectiveness factor
greater than one whereas the Mayak workforce apparently does. This differ-
ence could be a chance effect, but it could also point to potential problems with
these worker studies. Of particular concern is the adequacy of recorded doses
received in the early years of operations at older nuclear installations, such as
the potential for ‘missed’ photon doses. A further issue is how baseline cancer
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rates may influence radiation-related excess risks. There is scope for a consid-
erable increase in the statistical power of worker studies, with longer follow-up
capturing more deaths and incident cases of cancer, and further workforces
being included in collaborative studies, but the difficulties posed by dosimetry
questions should not be ignored and need to be the subject of detailed scrutiny.
Keywords: cancer risk, low-level radiation exposure,
nuclear workers, dose uncertainties
(Some figures may appear in colour only in the online journal)
1. Introduction
In the current international system of radiological protection [1] the health detriment con-
sequent to low-level exposure to ionising radiation—that is, the risk to health arising from the
receipt of low doses of radiation or doses received at a low dose-rate—is posited to be due
primarily to an excess risk of cancer in the exposed individual. Quantification of the radiation-
related excess risk of cancer is obtained from statistical models principally derived from the
experience of the Japanese survivors of the atomic-bombings of Hiroshima and Nagasaki in
1945, in particular, from the Life Span Study (LSS) cohort of∼86 500 survivors alive in Octo-
ber 1950. However, not all risk models depend on the LSS data, some being derived from other
exposure circumstances, notably the risk model for lung cancer following inhalation of radon
and its short-lived radioactive decay products, which is obtained from studies of underground
hard-rockminers. The atomic-bomb survivors were briefly and relatively uniformly exposed to
mainly gamma radiation (with, in general, a small component of neutrons), so certain assump-
tions are necessary when other exposure conditions are under consideration, such as protracted
exposure, levels of exposure that differ between organs/tissues, or exposure to other types of
radiation (such as alpha-particles).
Groups of people exposed to radiation for medical purposes, in the environment and in the
workplace offer opportunities for epidemiological studies to provide evidence to complement
the findings of the studies of the atomic-bomb survivors [2–4]. Many of these studies are
difficult to conduct or interpret for a number of reasons, such as the influence of various biases
or confounding factors, poor exposure details and small numbers leading to low statistical
power [5]. However, studies of those occupationally exposed to radiation offer an increasingly
important source of information on the effects of protracted low dose-rate exposure to external
sources of radiation, and some workers have also been exposed to internal sources of radiation
as a result of intakes of radionuclides such as plutonium [6]. This paper reviews the most
powerful of these worker studies, what scope there is for their expansion and enhanced power,
and what problems remain to be resolved. The paper concentrates on studies of exposure to
external sources of radiation although important progress is also being made in investigating
the effects of exposure from internally deposited radionuclides, e.g. radon decay products [7]
and plutonium [8].
2. Studies of nuclear workers in Western Europe and North America
2.1. The International Nuclear Workers Study (INWORKS)
For several decades, efforts have been made to combine data for workers from a number
of nuclear installations to improve statistical power, initially at a national level and then
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Figure 1. Distributions of (a) the annual number of workers monitored for exposure to
external radiation averaged over a calendar period (generally, 5 years) and the collective
photon Hp(10) dose (person.dSv = person.Sv × 10) received in a calendar period in
INWORKS [14], and (b) the number of workers in each cumulative photonHp(10) dose
group in INWORKS [13].
internationally. The first international study involved workers from the USA, Canada and the
UK [9], followed by the 15-country worker study [10, 11], and most recently INWORKS [12,
13]. INWORKS is a study of cancer mortality that includes ∼308 300 workers from the UK,
France and five sites in the USA. This collaborative study is of particular importance because
it includes workers from a number of early nuclear weapons facilities (e.g. Hanford, USA;
Sellafield, UK; Marcoule, France), many of whom received annual doses in the initial years
of operations that would not be acceptable today; a comparatively large proportion of these
early workers accumulated occupational external doses over their working lifetimes in excess
of 100 mGy.
In INWORKS, the mean cumulative photon (mainly external gamma) Hp(10) dose is
∼25 mSv and the collective photon Hp(10) dose is ∼7770 person.Sv; of this collective dose,
∼60% was received during 1960–1979 (a combination of comparatively large numbers of
workers receiving, on average, annual photon Hp(10) doses of 2–4 mSv during this period)
and ∼15% before 1960 [12, 14] (figure 1(a)); the distributions of annual doses and workers
for each of the three countries have been provided by Thierry-Chef et al [15]. INWORKS cur-
rently includes ∼19 750 cancer deaths with follow-up to the end of 2005, 2001 and 2004 for
the USA, UK and France, respectively. Importantly for power, almost 20 000 workers (6%)
in INWORKS accumulated lifetime occupational photon doses exceeding 100 mSv, includ-
ing more than 1000 workers with lifetime doses greater than 500 mSv [13, 14] (figure 1(b)).
However, it is important to appreciate that these moderate-to-high cumulative doses consist
of many small doses received at a low dose-rate over protracted periods, usually many years,
and therefore these exposure circumstances are of direct relevance to radiological protection
against low-level exposures.
To date, INWORKS is the most powerful study of nuclear workers fromWestern European
and North American installations addressing the effect of protracted low-level radiation expos-
ure on the risk of cancer mortality. However, at present, INWORKS includes workers from
just five sites in the USA: Hanford, Savannah River, Oak Ridge National Laboratory (ORNL),
Idaho National Laboratory and Portsmouth Naval Shipyard. Consequently, there is consider-
able scope for expanding the number of workers from North America included in international
collaborative studies. In this respect, the Million Worker Study (MWS) currently underway in
the USA [16, 17] has the potential for substantially increasing the number of US workers
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Figure 2. Dose-responses obtained from INWORKS [19, 20] in terms of the occupa-
tional photon dose accumulated over a working lifetime, for mortality from (a) leuk-
aemia (excluding CLL) using a 2 years RBM-dose-lag, and (b) all cancers excluding
leukaemia using a 10 years colon-dose-lag. Error bars and bands represent 95% confid-
ence intervals.
included in studies of those occupationally exposed to radiation, as illustrated by the recent
publication from the MWS of the results of a study of workers from Los Alamos National
Laboratory [18].
The principal findings of INWORKS are linear dose-responses describing the increase of
the relative risk of cancer mortality with increasing cumulative photon dose; no departures
from linear dose-responses were detected. The slopes of the dose-responses (the excess relative
risk (ERR) of mortality per unit organ/tissue-specific absorbed dose, ERR/Gy) are illustrated
in figure 2. For leukaemia (excluding chronic lymphocytic leukaemia, CLL, now classified
as a type of non-Hodgkin lymphoma), ERR/Gy = 2.96 (95% confidence interval; CI: 0.83,
5.64), based upon 531 deaths and red bone marrow (RBM) doses with a 2 years lag [19]. For
all cancers excluding leukaemia, ERR/Gy = 0.48 (95% CI: 0.15, 0.85), based upon 19 064
deaths and colon doses with a 10 years lag [20], while for all solid cancers combined (all
cancers excluding leukaemia, lymphoma and multiple myeloma), ERR/Gy = 0.47 (95% CI:
0.12, 0.85), based upon 17 957 deaths and colon doses with a 10 years lag [20]; a 5 years
dose-lag reduces these ERR/Gy estimates by ∼20% [20].
Somewhat surprising is the absence of published details of the effects of the modifications
made for INWORKS to the individual databases used in the separate US, UK and French stud-
ies; for mortality from all cancers excluding leukaemia, the ERR/Sv estimates for these three
national studies are 0.14 (95% CI: −0.17, 0.48) [21], 0.28 (95% CI: −0.03, 0.62) [22] and
0.34 (95% CI: −0.73, 1.58) (for all solid cancers combined [23]), respectively, which com-
pares with the overall INWORKS ERR/Gy estimate of 0.48 (95% CI: 0.15, 0.85) [20]. The use
of colon doses in INWORKS rather than Hp(10) doses led to an increase of nearly 40% in the
overall risk estimate from an ERR/Sv of 0.35 (95%CI: 0.10, 0.61) [20], but this ERR/Sv estim-
ate is still larger than those from each of the national studies. There are other differences that
are likely be relevant, such as the restriction in INWORKS to the inclusion of workers who had
been employed for at least 1 year, a selection criterion that was not adopted by the original US
and UK workforce studies [21, 22], suggesting that short-term employed workers may influ-
ence the ERR/Gy estimates for these countries. Different approaches to adjusting for various
factors were also adopted in the INWORKS analyses, and this could also affect comparisons.
For example, the main ERR/Gy estimate for all cancers excluding leukaemia in INWORKS,
0.48 (95% CI: 0.15, 0.85), is adjusted for neutron exposure monitoring status, but when no
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Figure 3. Dose-responses for mortality from all cancers except leukaemia from
INWORKS with a 10 years colon-dose-lag, for all workers and the contribution made
by the 94% of workers with cumulative photon doses to the colon <100 mGy [20]. Error
bars and bands are 95% confidence intervals.
such adjustment is made, the ERR/Gy reduces by nearly 60% to 0.20 (95% CI: −0.07, 0.50).
The treatment in INWORKS publications of the impacts of the various choices made in the
INWORKS analyses in relation to those made in the separate national studies is disappoint-
ingly opaque.
Of some interest is the contribution to the power of INWORKS of those workers who
accumulated moderate-to-high photon doses: although workers with cumulative colon doses
<100mGy represent 94% of the INWORKS study population, who generate for mortality from
all cancers except leukaemia an ERR/Gy = 0.81 (95% CI: −0.14, 1.80), the 6% of workers
with lifetime doses >100mGy are influential in their downwards leverage of the dose-response,
producing an overall ERR/Gy estimate for the full range of cumulative photon doses to the
colon of 0.48 (95% CI: 0.15, 0.85) [20], i.e. a reduction in the slope of the dose-response of
around 40% (see figure 3). It would be expected that much of the collective dose for those
workers accumulating doses >100 mGy would have been received during 1960–1979 (see
figure 1(a)), but it is not possible from published data to establish how much influence on the
slope of the dose-response might be exerted by doses received before 1960, and these early
doses could be a significant component of the cumulative doses of those workers receiving the
highest lifetime doses who provide the greatest leverage on the dose-response. This could be
an important issue (see discussion below on the accuracy of recorded doses).
Of importance is how the ERR/Gy estimates from INWORKS compare with the equivalent
estimates obtained from the LSS. Recently, Leuraud et al [24] havemade a detailed comparison
of dose-responses for leukaemia (excluding CLL) and all solid cancers combined (and all solid
cancers excluding lung cancer) that may be obtained from INWORKS and the LSS, selecting
the subgroups for comparison as being as similar as possible in terms of factors such as age-
at-exposure and sex, and using LSS mortality (rather than incidence) data. Doses were lagged
by 5 years for all analyses. The results of fits using linear models are shown in table 1; note
that significant upward curvature was reported for the leukaemia dose-response for the LSS.
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Table 1. Estimates of the slopes of the dose-responses, ERR/Gy and 95% confidence
intervals, obtained from INWORKS and the LSS using linear models for mortality from
leukaemia (excluding CLL), all solid cancers combined, and all solid cancers excluding
lung cancer. RBM doses were used for leukaemia (excluding CLL) and colon doses
were used for all solid cancers combined and all solid cancers excluding lung cancer.










INWORKS 3.15 (0.73, 6.21) 0.29 (0.03, 0.58) 0.25 (−0.07, 0.58)
LSS 2.75 (1.53, 4.49)b 0.28 (0.16, 0.40) 0.25 (0.12, 0.38)
a The small number of deaths from CLL in the LSS cohort could not be excluded.b Obtained from
a linear fit. A linear-quadratic model provided a significantly better fit, with a linear ERR/Gy
coefficient of 0.10 (95% CI: −1.25, 1.76) and a quadratic ERR/Gy2 coefficient of 1.61 (95%
CI: 0.66, 2.88).
The current scheme of radiological protection applies a dose and dose-rate effectiveness
factor (DDREF) of 2 to halve the slope of dose-responses for solid cancers obtained from the
LSS [1]. The INWORKS result does not lend obvious support to the application of a DDREF
of 2 to the LSS dose-response for solid cancers to obtain a ERR/Gy estimate appropriate for
low-level exposures.
2.2. The UK National Registry for Radiation Workers (NRRW)
The data from the UK contributing to INWORKS were from the 3rd analysis of the NRRW,
which included workers who started being monitored for exposure to external radiation dur-
ing 1940–1999 and who were followed-up until the end of 2001 [22]. NRRW-3 workers
represent around half of the workers, the collective dose and the workers with cumulative
doses >100 mGy included in INWORKS [13]; almost 40% of the cancer deaths included
in INWORKS were from the NRRW-3 database [12]. Figure 4 illustrates the importance in
NRRW-3 of those workers employed in the early years of operations, with ∼23 600 of work-
ers (14%) who started work before 1960 accounting for ∼40% of the overall collective dose
and including ∼40% of the workers who accumulated lifetime occupational external doses
>100 mGy [25].
NRRW-3 has now been updated [26] to include deaths among those whose monitoring for
exposure to external radiation commenced during 1940–2001 and with follow-up extended a
further 10 years to the end of 2011, which increased the number of deaths from all cancers
excluding leukaemia contributing to the dose-response analysis by 52% from 7455 to 11 329.
Nearly 35 000 workers (∼20% of all workers in NRRW-3) had died before 2012. Figure 5(a)
shows the distributions by calendar period of starting radiation work and cumulative external
radiation dose of all workers and of those workers who had died before 2012, and figure 5(b)
shows these deaths expressed as a percentage of all workers in a particular lifetime dose/cal-
endar period cell. Of interest is that 57% of all workers (and 37% of workers who started work
before 1960) with external doses >100 mGy over a working lifetime were still alive at the end
of 2011, so there is substantial information still to come from the NRRW, and by extension,
INWORKS.
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Figure 4. Distributions of mean lifetime occupational external dose (mSv) and collect-
ive lifetime occupational external dose (person.daSv= person.Sv/10) by calendar period
of first monitoring for exposure to radiation, from the NRRW-3 database for follow-up
to the end of 2001 [25].
Figure 5. Distributions by calendar period of starting radiation work during 1940–2001
and by cumulative external dose group of (a) the numbers of all workers and of deceased
workers, and (b) the percentages of deceased workers, from the updated NRRW-3 data-
base with follow-up until the end of 2011 [26].
3. Studies of workers from the Mayak nuclear installation in Russia
TheMayak nuclear installation in the Southern Urals of Russia commenced operations in 1948
and was the first weapons plutonium production facility in the former USSR. Exposures to
external radiation and plutoniumwere particularly high before 1960, and a cursory comparison
of figures 6 and 1(b) is sufficient to reveal that photon doses accumulated by Mayak workers
tended to be considerably larger than those by workers included in INWORKS, with almost
one-fifth of the Mayak workforce receiving cumulative photon doses in excess of 1 Sv.
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Figure 6. The number of Mayak workers in each cumulative photon Hp(10) dose
group [27].
Results have been published from recent studies of the incidence of leukaemia (exclud-
ing CLL) among ∼22 400 Mayak workers [28], and mortality from solid cancers exclud-
ing lung, liver and bone cancers among ∼25 800 workers [29], in relation to photon (largely
external gamma) dose—the risk of cancers of the lung, liver and bone is expected to be raised
after intakes of plutonium because plutonium deposits in these organs, so these cancers were
excluded from the analysis of solid cancer mortality to reduce the influence of plutonium
exposures on the findings for external radiation exposure.Mean cumulative photon doses to the
RBM and colon were ∼390 mGy and ∼350 mGy, respectively [28, 29]; ∼45% of the person-
years of follow-up had cumulative photon doses to the colon exceeding 100 mGy and ∼10%
exceeding 1 Gy [29]—the power of theMayak studies derives from the magnitude of the doses
received and their range, in combination with the number of workers accumulating moderate
and high doses. The wide range of cumulative photon doses received by Mayak workers will
be appreciated from figure 6, but it should be emphasised that even lifetime doses of several
gray will have been accumulated as many small doses received at a low dose-rate over many
years and therefore moderate and high cumulative doses received by Mayak workers are of
relevance to the assessment of risks from low-level exposures.
No significant departures from linear dose-responses were found in these two studies of
the Mayak workforce [28, 29] and the dose-responses are illustrated in figure 7. The ERR/Gy
estimate for the incidence of leukaemia excluding CLL of 3.57 (95% CI: 1.16, 9.11) is based
upon 56 incident cases and RBM doses lagged 2 years [28], while the ERR/Gy for mortality
from all solid cancers excluding lung, liver and bone cancers of 0.12 (95% CI: 0.03, 0.21) is
based upon 1825 deaths and colon doses lagged 5 years [29]. When the analysis of mortality
from all solid cancers excluding lung, liver and bone cancers was restricted to Mayak workers
who were unlikely to have experienced substantial intakes of plutonium, the ERR/Gy was 0.20
(95% CI: 0.0, 0.46) [30].
Shown in table 2 are the results of a comparison conducted by Preston et al [31] of ERR/Gy
estimates derived from the Mayak workers and members of the LSS cohort exposed as adults;
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Figure 7. Linear dose-responses, ERR/Gy, derived from studies of the Mayak work-
force, in terms of lifetime occupational photon doses, for (a) incidence of leukaemia
(excluding CLL) with doses to the RBM lagged by 2 years [28], and (b) mortality from
all solid cancers excluding lung, liver and bone cancers with doses to the colon lagged
by 5 years [29]. Error bars and bands are 95% confidence intervals.
Table 2. Estimates of the slopes of the dose-responses, ERR/Gy and associated 95%
confidence intervals, obtained from the Mayak workforce and the LSS cohort, for leuk-
aemia (excluding CLL), for all solid cancers excluding lung, liver and bone cancers, and
for lung cancer [31]. RBM doses are used for leukaemia and colon doses for solid can-














0.86 (−1.4, 5.2) 0.46 (0.18, 0.85) 0.42 (0.11, 1.1)
for Mayak, mortality data only were used, while for the LSS, incidence data were used for the
analysis of leukaemia and mortality data for solid cancers. The ERR/Gy estimates presented in
table 2 for Mayak workers are notably lower than those for the LSS cohort. However, care in
interpretation is required, because the ERR/Gy for leukaemia (excluding CLL) for the Mayak
workforce using incidence data has been reported as 3.57 (95% CI: 1.16, 9.11) (see above
[28]), i.e. markedly larger than that shown in table 2 for Mayak, using mortality data. Further,
Leuraud et al [24] obtained a leukaemia ERR/Gy for the LSS cohort using mortality data of
2.75 (95% CI: 1.53, 4.49) (see table 1, but note footnote b to table 1), which is notably larger
than the estimate for leukaemia incidence in the LSS shown in table 2.
4. Potential problems that need to be addressed
4.1. Implications of the INWORKS and Mayak findings for the value of the DDREF
As noted above, in the current international system of radiological protection, a DDREF of
2 is applied to solid cancer risk estimates derived from moderate-to-high doses received at a
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high dose-rate by survivors in the LSS cohort to generate risk estimates deemed appropriate
for application to low-level exposures [1]. What evidence for such a halving of the slope of
the dose-response is available from worker studies? It is rather contradictory, with INWORKS
offering little support whereas the Mayak workforce provides rather stronger support. Figure 8
compares the linear ERR/Gy dose-responses for mortality from all solid cancers excluding
lung cancer as derived from the LSS and INWORKS [24], and for mortality from all solid
cancers excluding lung, liver and bone cancers as obtained from Mayak [31]; figure 8 sum-
marises the results presented in tables 1 and 2.
It is unlikely that the slope of the Mayak dose-response shown in figure 8 would change
materially if just lung cancer was able to be excluded from all solid cancers because liver
and bone cancers make a relatively minor contribution to solid cancers [32]. Nonetheless, the
impact of differences in data and modelling must be borne in mind: Leuraud et al [24] derived
an ERR/Gy from the LSS for mortality from all solid cancers excluding lung cancer of 0.25
(95% CI: 0.12, 0.38) (table 1 and figure 8), whereas Preston et al [31] obtained a rather higher
ERR/Gy from the LSS for mortality from all solid cancers excluding lung, liver and bone
cancers of 0.46 (95% CI: 0.18, 0.85) (table 2). In a similar vein, although the ERR/Gy for
leukaemia (excluding CLL) mortality obtained from INWORKS, 3.15 (95% CI: 0.73, 6.21),
might appear to be compatible with that for leukaemia (excluding CLL) incidence derived
from Mayak, 3.57 (95% CI: 1.16, 9.11), the INWORKS estimate is driven by the ERR/Gy for
mortality from chronic myeloid leukaemia, 10.45 (95% CI: 3.34, 21.41), whereas the Mayak
estimate is driven by the ERR/Gy for acute myeloid leukaemia incidence, 13.23 (95%CI: 2.53,
56.39).
The difference between the ERR/Gy estimates from INWORKS and the Mayak workforce
needs to be properly understood—is this just a chance difference, given that the statistical
uncertainties currently associated with the INWORKS estimate are comparatively large, or
are systematic effects present, and if so, to what degree do they influence each dose-response?
The answers to these questions are of some importance, since reliable conclusions concerning
the appropriate DDREF to use for the purposes of radiological protection depend on a proper
understanding of the apparent conflict in the inferences to be drawn from the risk estimates
derived from these two nuclear worker studies [33, 34]. There are other issues that need to be
considered when assessing the DDREF, such as the appropriate relative biological effective-
ness (RBE) applicable to the neutrons to which the atomic bomb survivors were exposed, and
how the RBE varies with the spectra of photon energies experienced during the atomic bomb
explosions and occupationally [24].
One important issue that requires further scrutiny in the deliberations onDDREF and related
matters is the impact on radiation dose-responses of baseline cancer rates (i.e. the cancer rates
in the absence of the specific exposure(s) to radiation under consideration). The ERR expresses
the proportional increase in the cancer rate in comparison with the baseline rate, whereas the
excess absolute rate (EAR) is the additional rate above the baseline rate. The ERR and the
EAR are alternative ways of quantifying an increased risk, but the difference in these meas-
ures becomes important when comparing radiation effects between populations with different
baseline rates. Which comparison is the more appropriate depends on how radiation interacts
with other risk factors: if there is a multiplicative interaction between radiation and the other
major risks then ERR/Gy will be the same for the two populations, but if there is no interaction
then the risks add and EAR/Gy will be the same for the two populations. The absence of an
interaction between radiation and other risk factors implies that the radiation-related excess
number of cases/deaths is independent of the baseline rate, but otherwise dependent (to some
degree). Whether the ERR/Gy or the EAR/Gy (or some combination of the two if there is a
submultiplicative interaction) is considered to be the appropriate comparison when baseline
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Figure 8. Linear dose-responses, ERR/Gy, for mortality from all solid cancers exclud-
ing lung cancer obtained using cumulative photon doses to the colon, for the LSS cohort
[24], the Mayak workforce (for all solid cancers excluding lung, liver and bone cancers
[31]) and INWORKS [24], with doses lagged by 5 years. Error bands are 95% confid-
ence intervals.
rates differ will depend on the evidence for an interaction between radiation and other risk
factors, although in most cases such evidence will be limited [35]. To illustrate the potential
importance of this issue, consider the EAR/Gy for all solid cancers combined derived by Leur-
aud et al [24] from the LSS and INWORKS: respectively, 7.64 (95% CI: 2.56, 13.65) and 1.32
(95% CI: <0, 8.20) excess deaths per 104 person-year.Gy for an attained age <80 years. This
difference contrasts with that for the ERR/Gy estimates of 0.28 (95% CI: 0.16, 0.40) and 0.29
(95% CI: 0.03, 0.58), respectively, although interpretation is not straightforward because of
differences in the attained age distributions of the two cohorts. This example serves to sound a
cautionary note about comparisons between risk estimates derived from populations with dif-
ferent baseline cancer rates, as is the case with the LSS, INWORKS and Mayak—inferences
about DDREF should not be restricted to comparisons between ERR/Gy dose-responses alone,
but relevant information is currently limited.
4.2. The accuracy of doses used in nuclear worker studies
Various aspects of nuclear worker studies need to be examined carefully to ensure that risk
estimates are as accurate as available data permit. One important issue is the level of confid-
ence in the suitability for use in epidemiological studies of doses recorded for the purposes of
regulatory requirements and radiological protection, which has been the subject of a number
of examinations [14, 36–38]. In INWORKS, recorded photon doses have been converted to
Hp(10) doses and organ/tissue-specific absorbed doses [15], the latter being used in the epi-
demiological analyses [19, 20]; but it is unclear whether the adjustments to recorded doses
are sufficient for some workers in the cohorts contributing to INWORKS, especially for doses
received before 1960 byworkers who accumulated comparatively high doses during this period
[36, 39].
1085
J. Radiol. Prot. 41 (2021) R Wakeford
Figure 9. The distributions of average annual individual external doses received by
workers during the earlier years of operations at the irradiated nuclear fuel reprocessing
installations at (a) Mayak (in the former USSR) [27] and (b) Sellafield (in the UK) [42,
43], showing dose distributions in relation to when reprocessing operations began.
In this respect, the temporal distributions of annual doses from external sources of radiation
in the early years of operations at certain older installations are relevant. At the Mayak and
Sellafield nuclear complexes, average annual individual external doses were highest in the first
few years after irradiated nuclear fuel reprocessing commenced in late-1948 and early-1952,
respectively, and then steadily reduced with time [40, 41], as illustrated in figure 9 [27, 42].
The demands of familiarisation with operations requiring the large-scale handling of irradi-
ated nuclear fuel under political pressure to rapidly extract plutonium for the production of
the first nuclear weapons in the two countries upon average doses received after reprocessing
commenced is clear, and is especially apparent in the high doses received at Mayak (figure 9).
Sellafield workers are an important component of NRRW-3 (and therefore INWORKS): work-
ers based at Sellafield contributed to the NRRW-3 database nearly 40% of the collective dose
and 44% of the workers with lifetime doses >100 mSv [25].
These temporal patterns of average annual external doses at Mayak and Sellafield con-
trast with those for Hanford and Savannah River [44, 45], two of the US facilities included
in INWORKS. It will be seen from figure 10(a) that in the early years of operations at Han-
ford (where irradiated nuclear fuel reprocessing began in late-1944) average annual recorded
external doses received by monitored workers were only ∼1−2 mSv (the annual numbers of
monitoredworkers during 1945–1950were 4000–7000 [44]). This low level of annual doses is,
perhaps, surprising when contrasted with the average annual external doses of around 15 mSv
for workers monitored for exposure to external radiation (and around 11 mSv for all workers,
both monitored and unmonitored) recorded at Sellafield in the mid-1950s, soon after repro-
cessing operations began (the annual numbers of monitored workers during 1952–1958 were
2000–4000; in this early period of operations at Sellafield the monitored workers were pre-
dominantly men [43]). It would appear that the differences in average annual external doses
between Hanford and Sellafield cannot be explained just by the numbers of workers who were
monitored for radiation exposure during these early periods. Similarly low average annual
external doses were recorded at Savannah River following the commencement of reprocessing
operations in late-1954 (figure 10(b)).
However, also shown in figure 10 are the average annual external doses reconstructed for
the purposes of the US worker compensation programme [46], and there is a considerable gap
between recorded and reconstructed doses at Hanford and Savannah River, but importantly,
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Figure 10. Comparison of the distributions by calendar year of average annual indi-
vidual whole-body doses received occupationally from penetrating (primarily photon)
radiation from external sources, as recorded at the US nuclear installations at (a) Hanford
[44] and (b) Savannah River [45], and as reconstructed [46] for the purposes of com-
pensating people who develop cancers that could be attributable to prior occupational
exposure to radiation at these installations. Reproduced from [47]. CC BY 4.0.
only for the early years of operations at the sites. It must be expected that (possibly substantial)
generosity will be built into a worker compensation programme, so the reconstructed doses
would be anticipated to overestimate actual doses, but the shapes of the reconstructed external
dose distributions at Hanford and Savannah River are much closer to those at Mayak and
Sellafield in the early years of operations (see figure 9).
These dose reconstructions at Hanford and Savannah River beg the question as to the extent
of the adjustments to early recorded external doses that may be required for epidemiological
purposes when workers from older nuclear installations are included in studies. Are those dose
adjustments that have already been made for INWORKS sufficient? It may be, however, that
there are sound reasons for comparatively low levels of external exposure soon after irradi-
ated nuclear fuel reprocessing began at these two US facilities, such as the design of plant in
terms of radiological protection of personnel. Gilbert et al [48–50] scrutinised external dose
uncertainties at Hanford and found indications that adjustments to recorded external doses
were required, particularly in the earlier years of operations, but little evidence that substantial
underestimates of external doses were widespread at Hanford.
Even so, questions have been raised about the adequacy of dose records for use in epidemi-
ological studies at other sites, including the matter of ‘missing’ photon doses for early workers
at ORNL [51], another US facility included in INWORKS, although the impact of this source
of dose uncertainty is unclear [52]. This subject does need to be investigated in some depth,
particularly those features of the dose reconstructions at Hanford and Savannah River, con-
ducted for the purposes of worker compensation, that led to the upwards revisions in recorded
doses in the early years of operations at the two sites, and whether, to some extent, these
factors need to be additionally accounted for in external doses used in epidemiological studies
that include US installations, such as INWORKS and the MWS. Those reviewing INWORKS
dosimetry have stressed the importance of pursuing dose uncertainties and their impact upon
risk estimates. Till et al [36] observed:
‘The dosimetry is also quite difficult to verify from the open literature because it
involves several layers of independent epidemiological studies that reach back
almost four decades and because of the inaccessibility of the original dosimetry.
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The sheer technical challenge of the dosimetry and the positive findings of the
epidemiology stress the importance of making the dosimetry as state-of-the-art,
complete, and thorough as possible since minor variations in the cumulative
dose could impact the outcome of the study. Work remains to fully verify the
dosimetry methodology and to be certain that adjustments to historical doses
have been properly taken into account and that uncertainties and bias have been
thoroughly addressed’.
Daniels et al [14] remarked:
‘Nevertheless, dose estimation errors were unavoidable, especially during the
early years when contributions to individual dose from [below detection limit]
doses, neutrons, and [work-related x-ray examinations] could be substan-
tial. The potential effects on the dose-response from these sources remain
unclear’.
It would be most surprising if similar dosimetry concerns were not apparent at other older
nuclear installations. Indeed, the subject of Sellafield dosimetry uncertainties was addressed
25 years ago by a paper at the IRPA9 Congress [41]. In the UK, the issue of ‘missing’ photon
doses in the early years of operations at UK Atomic Energy Authority (UKAEA) establish-
ments was examined in some detail, finding that substantial adjustments to external dose
records at certain installations were required before 1961 [53]. These adjustments were incor-
porated into the NRRW dosimetry database for the purposes of the NRRW-2 analysis [54],
and carried over into the NRRW-3 analysis [22]. Sensitivity analyses conducted for NRRW-3
indicated that dose adjustments reduced the ERR/Sv estimates for mortality from all cancers
excluding leukaemia by around 10%, although the adjustments carried out for some estab-
lishments, e.g. Sellafield, were less comprehensive than those made to historical doses at the
UKAEA sites [25].
What of the accuracy of the Mayak external dose records in the early years of opera-
tions? Work examining external dosimetry at Mayak for the purposes of construction of the
‘Doses-2005’ database has been reported [40], but few details have been published of any fur-
ther investigations for subsequent external dosimetry databases [36], including the recently
published analysis of the impact on risk estimates of dosimetry uncertainties at Mayak [55],
which largely concentrated on uncertainties in lung doses from plutonium. Again, it would
be of value in reaching reliable inferences on risk estimates if more information on external
photon doses and their uncertainties was available for Mayak, and for other older nuclear
installations.
It could be argued that any revisions to early photon doses would be unlikely to influence
to any significant extent the slopes of dose-responses because most of the collective dose was
received in later years when dose uncertainties were less—for example,∼60% of the recorded
collective photon dose in INWORKS was received during 1960–1979 [14] (figure 1(a)). How-
ever, as figure 3 illustrates, the 6% of workers in INWORKS who have accumulated photon
doses >100 mGy have a considerable leverage effect on the dose-response, and systematic
underestimation of some historical doses for those receiving the highest lifetime doses could
well affect the slope of the dose-response—although only 15%of the collective photon dose for
INWORKS was received before 1960, these early doses could have a disproportionately large
effect on the slopes of the dose-responses because it wasmainly received byworkers who accu-
mulated the highest lifetime doses. Unfortunately, the proportion of workers in INWORKS
with lifetime photon doses exceeding 100 mGy who started radiation work before 1960 has
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not been published, but 42% of those workers in NRRW-3 who accumulated external doses
>100 mSv started to be monitored for external exposure before 1960. Given the implications
for, inter alia, the DDREF (if any) and its use in radiological protection, it would be well
worthwhile investigating this issue further.
In this respect, one initial approach to assessing the potential influence of early photon dose
uncertainties upon the slopes of the dose-responses would be to perform analyses with data
restricted to workers who started being monitored for exposure to external radiation either
before or after 1960, given that uncertainties in photon dose records are likely to be greater in
the period before 1960 [14, 36]. If photon dose uncertainties in the earlier years have a signi-
ficant influence upon dose-responses, then this could be apparent from such an investigation;
but of course, the problem with this approach is that the available data are divided in two,
leading to a loss of statistical power and greater statistical uncertainties in the slopes of the
dose-responses. Nonetheless, although addressing mortality from diseases of the circulatory
system rather than from cancer, a similar division of workers by earlier and later periods of
first employment at Mayak and Sellafield produced some intriguing differences in the dose-
responses for the two periods [27]. Such an initial ‘broad-brush’ approach to investigating the
impact of early doses upon dose-responses could be a useful first step.
It will have been noted that risk estimates in terms of occupational exposure from external
sources have, to date, only considered photon doses in any detail; neutron doses have not been
assessed quantitatively. Further, the impact upon external exposure risk estimates of doses
from intakes of radionuclides has not been addressed in any comprehensive manner, although
radionuclide monitoring status has been used to adjust photon risk estimates in some analyses,
such as at Mayak. Uncertainties in neutron doses were considerable in the early years of the
nuclear industry and persisted into the 1970s, if not later; some neutron exposures will not
have been monitored and some potentially large neutron doses will not have been recorded
[15, 36, 39–41]. As noted earlier, one puzzling finding from INWORKS is that the primary
ERR/Gy estimate for photon doses and all cancers except leukaemia, which was adjusted
for neutron monitoring status, 0.48 (95% CI: 0.15, 0.85), reduced by ∼60% to 0.20 (95%
CI: −0.07, 0.51) when no such adjustment was made. This may be a chance effect, but it may
also be related to inadequacies in neutron monitoring information and potential confounding
effects [20, 39]. A further perplexing result from INWORKS is that when the analysis was con-
fined to the 83% of workers who were not monitored for intakes of radionuclides, the ERR/Gy
for all cancers except leukaemia increased by 50% to 0.72 (95% CI: 0.21 and 1.28); similar
increases in external exposure risk estimates for workers not monitored for potential exposure
to internal emitters when compared with those for workers who were monitored for internal
exposures has been noted in other studies [56].
These findings indicate that it will be necessary to properly understand the impact of the
inclusion of neutron and internal doses in the analyses before confident inferences may be
reached on the accuracy of risk estimates for photon doses, and other sources of radiation
exposure also exist that have yet to be taken into account, such as exposures to x-rays at medical
examinations required for employment in the nuclear industry [14]. A point to consider is that
the size of doses from sources so far unaccounted for in studies may be positively correlated
with the size of recorded photon doses (and the size of photon dose inaccuracies), so that the
impact of photon dose uncertainties on dose-responses may be amplified by these other dose
uncertainties. The potential consequences of these additional doses for risk estimates must be
assessed to be able to draw reliable conclusions, but this is likely to involve substantial work
if done properly.
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5. Conclusions
Large-scale radiation worker studies, such as INWORKS and the MWS, must continue
because they have the potential to provide important information on radiation risks pertinent
to everyday radiological protection against protracted low-level exposures.
There is a need to:
• Expand the nuclear workforces included, particularly workers from those facilities in the
USA that are not currently included in international collaborations, but also, at an appro-
priate time, from other countries with suitable databases, such as Canada.
• Continue follow-up of workers, especially those employed in the early years of nuclear
operations who received substantial cumulative doses, to achieve greater power by includ-
ing more deaths and incident cases of cancer in analyses.
• Improve dosimetry, not only those components of occupational doses that are not presently
included (neutrons and internal emitters), but also to ensure that photon doses are as accurate
as possible, through dose reconstruction in the early years of nuclear operations, if neces-
sary.
• In the absence of detailed dose reconstructions, examine approaches that might indicate
the potential effect of dose uncertainties upon risk estimates, such as excluding from ana-
lyses those workers starting employment before 1960 who are likely to be associated with
relatively greater dose uncertainties.
• In addition to examining radiation-related excess risks in terms of the usual use of ERR/Gy,
explore the use of EAR/Gy when baseline cancer rates differ between the populations under
study, and the implications upon inferences about DDREF and related issues (such as how
radiation interacts with other major risk factors).
These considerations on continued follow-up, accurate dosimetry and other matters also
apply to the Mayak workforce, which is a valuable source of information on protracted expos-
ures; they may also be relevant to studies involving workers from other, especially older, nuc-
lear installations.
Ultimately, it will be powerful epidemiological studies examining exposure conditions
of direct relevance to radiological protection against low-level radiation exposure that will
provide themost reliable evidence on the appropriateness of the assumptions currently required
to generalise from the experience of the Japanese atomic-bomb survivors acutely exposed to
mainly gamma radiation. This will mean addressing some difficult issues, such as the accuracy





[1] ICRP 2007 The 2007 recommendations of the International Commission on Radiological Protec-
tion. ICRP publication 103 Ann. ICRP 37 1–332
[2] Boice J D, Held K D and Shore R E 2019 Radiation epidemiology and health effects following
low-level radiation exposure J. Radiol. Prot. 39 S14–S27
[3] UNSCEAR 2008 UNSCEAR 2006 Report. Annex A: Epidemiological Studies of Radiation and
Cancer (New York: United Nations) pp 13–322
1090
J. Radiol. Prot. 41 (2021) R Wakeford
[4] McLean A R et al 2017 A restatement of the natural science evidence base concerning the health
effects of low-level ionizing radiation Proc. Biol. Sci. 284 20171070
[5] UNSCEAR 2018UNSCEAR 2017 Report. Annex A: Principles and criteria for ensuring the quality
of the Committee’s reviews of epidemiological studies of radiation exposure (New York: United
Nations) pp 17–64
[6] Wakeford R 2009 Radiation in the workplace—a review of studies of the risks of occupational
exposure to ionising radiation J. Radiol. Prot. 29 A61–A79
[7] Richardson D B et al 2021 Mortality among uranium miners in North America and Europe: the
pooled uranium miners analysis (PUMA) Int. J. Epidemiol. 50 633–43
[8] GilliesM et al 2017 Lung cancer risk from plutonium: a pooled analysis of theMayak and Sellafield
worker cohorts Radiat. Res. 188 645–60
[9] Cardis E et al 1995 Effects of low doses and low dose rates of external ionizing radiation: cancer
mortality among nuclear industry workers in three countries Radiat. Res. 142 117–32
[10] Cardis E et al 2005 Risk of cancer after low doses of ionising radiation: retrospective cohort study
in 15 countries BMJ 331 77
[11] Cardis E et al 2007 The 15-country collaborative study of cancer risk among radiation workers in
the nuclear industry: estimates of radiation-related cancer risks Radiat. Res. 167 396–416
[12] Laurier D et al 2017 The International Nuclear Workers Study (INWORKS): a collaborative epi-
demiological study to improve knowledge about health effects of protracted low-dose exposure
Radiat. Prot. Dosim. 173 21–25
[13] Hamra G B et al 2016 Cohort profile: The International Nuclear Workers Study (INWORKS) Int.
J. Epidemiol. 45 693–9
[14] Daniels R D et al 2020 Strengths and weaknesses of dosimetry used in studies of low-dose radiation
exposure and cancer J. Natl Cancer Inst. Monogr. 2020 114–32
[15] Thierry-Chef I et al 2015 Dose estimation for a study of nuclear workers in France, the United
Kingdom and theUnited States of America:methods for the International NuclearWorkers Study
(INWORKS) Radiat. Res. 183 632–42
[16] Boice J D Jr et al 2019 The million person study, whence it came and why Int. J. Radiat. Biol. 1–14
[17] Boice J D Jr. et al 2018 The past informs the future: an overview of the million worker study and
the Mallinckrodt chemical works cohort Health Phys. 114 381–5
[18] Boice J D Jr et al 2021 Mortality among workers at the Los Alamos National Laboratory, 1943–
2017 Int. J. Radiat. Biol. (https://doi.org/10.1080/09553002.2021.1917784)
[19] Leuraud K et al 2015 Ionising radiation and risk of death from leukaemia and lymphoma in
radiation-monitored workers (INWORKS): an international cohort study Lancet Haematol.
2 e276–81
[20] Richardson D B et al 2015 Risk of cancer from occupational exposure to ionising radiation:
retrospective cohort study of workers in France, the United Kingdom, and the United States
(INWORKS) BMJ 351 h5359
[21] Schubauer-Berigan M K et al 2015 Cancer mortality through 2005 among a pooled cohort of US
nuclear workers exposed to external ionizing radiation Radiat. Res. 183 620–31
[22] Muirhead CR et al 2009Mortality and cancer incidence following occupational radiation exposure:
third analysis of the National Registry for Radiation Workers Br. J. Cancer 100 206–12
[23] Metz-Flamant C et al 2013 Mortality associated with chronic external radiation exposure in the
French combined cohort of nuclear workers Occup. Environ. Med. 70 630–8
[24] Leuraud K et al 2021 Risk of cancer associated with low-dose radiation exposure: comparison of
results between the INWORKS nuclear workers study and the A-bomb survivors study Radiat.
Environ. Biophys. 60 23–39
[25] Muirhead C et al 2009 Third Analysis of the National Registry for RadiationWorkers: Occupational
Exposure to Ionising Radiation in Relation to Mortality and Cancer Incidence HPA-RPD-062
(Didcot, UK: Health Protection Agency)
[26] Haylock R G E et al 2021 Cancer mortality and incidence following external occupational radiation
exposure: an update of the 3rd analysis of the UK National Registry for Radiation Workers Br.
J. Cancer 119 631–7
[27] Azizova T V et al 2018 An assessment of radiation-associated risks of mortality from circulatory
disease in the cohorts of Mayak and Sellafield nuclear workers Radiat. Res. 189 371–88
[28] Kuznetsova I S, Labutina E V and Hunter N 2016 Radiation risks of leukemia, lymphoma and
multiple myeloma incidence in the Mayak cohort: 1948–2004 PLoS One 11 e0162710
[29] Sokolnikov M et al 2015 Radiation effects on mortality from solid cancers other than lung, liver,
and bone cancer in the Mayak worker cohort: 1948–2008 PLoS One 10 e0117784
1091
J. Radiol. Prot. 41 (2021) R Wakeford
[30] Sokolnikov M, Preston D and Stram D O 2017 Mortality from solid cancers other than lung, liver,
and bone in relation to external dose among plutonium and non-plutonium workers in the Mayak
worker cohort Radiat. Environ. Biophys. 56 121–5
[31] Preston D L et al 2017 Estimates of radiation effects on cancer risks in the Mayak worker, Techa
River and atomic bomb survivor studies Radiat. Prot. Dosim. 173 26–31
[32] Sokolnikov M E et al 2008 Lung, liver and bone cancer mortality in Mayak workers Int. J. Cancer
123 905–11
[33] Shore R et al 2017 Risk of solid cancer in low dose-rate radiation epidemiological studies and the
dose-rate effectiveness factor Int. J. Radiat. Biol. 93 1064–78
[34] Hoel D G 2018 Nuclear epidemiologic studies and the estimation of DREF Int. J. Radiat. Biol.
94 307–14
[35] Wakeford R 2012 Radiation effects: modulating factors and risk assessment—an overview Ann.
ICRP 41 98–107
[36] Till J E et al 2017 A review of dosimetry used in epidemiological studies considered to evaluate
the linear no-threshold (LNT) dose-response model for radiation protection Int. J. Radiat. Biol.
93 1128–44
[37] Fix J et al 1997 A retrospective evaluation of the dosimetry employed in an international combined
epidemiological study Radiat. Prot. Dosim. 74 39–53
[38] Thierry-Chef I et al 2007 The 15-country collaborative study of cancer risk among radiation work-
ers in the nuclear industry: study of errors in dosimetry Radiat. Res. 167 380–95
[39] NCRP 2018 Commentary No. 27: Implications of Recent Epidemiologic Studies for the Linear-
Nonthreshold Model and Radiation Protection (Bethesda, MD: National Council on Radiation
Protection and Measurements)
[40] Vasilenko E K et al 2007 Mayak worker dosimetry study: an overview Health Phys. 93 190–206
[41] Kite A and Anderson R 1996An overview of retrospective occupational dosimetry at BNFL IRPA9:
1996 Int. Congress on Radiation Protection (Vienna, Austria, 14–19 April 1996) vol 3, ed K
Duftschmid (Vienna, Austria: IRPA) pp 102–4
[42] Douglas A J, Omar R Z and Smith P G 1994 Cancer mortality and morbidity among workers at the
Sellafield plant of British Nuclear Fuels Br. J. Cancer 70 1232–43
[43] Smith P G and Douglas A J 1986 Mortality of workers at the Sellafield plant of British Nuclear
Fuels BMJ 293 845–54
[44] Buschbom R and Gilbert E 1993 Summary of Recorded External Radiation Doses for Han-
ford Workers 1944–1989 PNL-8909/AD-902 (Richland, WA (United States): Pacific Northwest
Laboratory)
[45] Taylor G et al 1995 A History of Personnel Radiation Dosimetry at the Savannah River Site, Aiken,
SC WSRC-RP-95-234 (Aiken, SC (United States): Westinghouse Savannah River Company)
[46] Merwin S E et al 2008 External dose reconstruction under Part B of the Energy Employees Com-
pensation Act Health Phys. 95 95–106
[47] Wakeford R 2018 The growing importance of radiation worker studies Br. J. Cancer 119 527–9
[48] Gilbert E S and Fix J J 1995 Accounting for bias in dose estimates in analyses of data from nuclear
worker mortality studies Health Phys. 68 650–60
[49] Gilbert E S, Fix J J and Baumgartner W V 1996 An approach to evaluating bias and uncertainty in
estimates of external dose obtained from personal dosimeters Health Phys. 70 336–45
[50] Gilbert E S 1998 Accounting for errors in dose estimates used in studies of workers exposed to
external radiation Health Phys. 74 22–29
[51] Frome E L et al 1997 A mortality study of employees of the nuclear industry in Oak Ridge, TN
Radiat. Res. 148 64–80
[52] Xue X, KimMY and Shore R E 2006 Estimation of health risks associated with occupational radi-
ation exposure: addressing measurement error and minimum detectable exposure level Health
Phys. 91 582–91
[53] Inskip H et al 1987 Further assessment of the effects of occupational radiation exposure in the
United Kingdom Atomic Energy Authority mortality study Br. J. Ind. Med. 44 149–60
[54] Muirhead C et al 1999 Occupational radiation exposure and mortality: second analysis of the
National Registry for Radiation Workers J. Radiol. Prot. 19 3–26
[55] Stram D O et al 2021 Lung cancer in the Mayak workers cohort: risk estimation and uncertainty
analysis Radiat. Res. 195 334–46
[56] Gillies M and Haylock R 2014 The cancer mortality and incidence experience of workers at British
Nuclear Fuels plc, 1946–2005 J. Radiol. Prot. 34 595–623
1092
